Review: Cardio vascular complication of diabetes mellitus

Journal of Applied Pharmaceutical Science

Volumn 1, Issue 4, 2011, Pages 01-06

  Patel, Chintan A ^a   Pathak, Nimish L ^a   Bhatt, Nayana ^a   Marya, Bhavna ^a   Gavania, Mahendra ^a   Trivedi, Hardik ^a  

^a C U Shah College of Pharmacy and Research   (India)

Author keywords

Complications; Insulate matrix; Management; Mechanism; Various systems play role in this mechanism

Indexed keywords

EID: 84857081515     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes. 1991; 40: 405-412.
2. Blann AD and Collum CN: Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemostas. 1994; 72: 151-154.
3. Charles R and Robert E: Insulin and oral drug for diabetes mellitus; Modern pharmacology in clinical application. 2010: 2(6); 763- 776.
4. Ceriello A, Bortolotti N, Motz E, Pieri C, Marra M, Tonutti L, Lizzio S, Feletto F, Catone B and Taboga C:Meal-induced oxidative stress and low density lipoprotein oxidation in diabetes, the possible role of hyperglycemia. Metabolism. 1999: 48; 1503-1508.
5. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Marchi E and Torella R: Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism. 1989: 38; 1162-1163.
6. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E and Bartoli E: Hyperglycemia-induced thrombin formation in diabetes; the possible role of the oxidative stress. Diabetes 1995: 44; .924 -928.
7. Ceriello A, Giugliano D, Quatraro A, Dello Russo P and Torella R: Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988: 31; 889-891.
8. Ceriello A, Taboga C, Tonutti L, Giacomello R, Stel G, Motz E and Pirisi M: Pos meal coagulation activation in diabetes mellitus; the effect of acarbose. Diabetologia 1996: 39; 469-473.
9. Ceriello A, Falleti E, Bortolotti N, Motz E, Cavarape A, Russo A, Gonano F and Bartoli E: Increased circulating ICAM-1 levels in type-2 diabetic patients; the possible role of metabolic control and oxidative stress. Metabolism 1996 : 45; 498 -501.
10. Ceriello A, Falleti E, Motz E, Taboga C, Tonutti L, Ezsol Z, Gonano F and Bartoli E: Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus; the possible role of oxidative stress. Horm Metab Res 1998: 30; 146 -149.
11. Chisholm DJ, Campbell LV, Kraegen EW: Pathogenesis of the insulin resistance syndrome (syndrome X). Clin Exp Pharmacol Physiol. 1997: 24;782-784.
12. Cominacini L, Fratta Pasini A, Garbin U, Davoli A, De Santis A, Campagnola M, Rigoni A, Zenti MG, Moghetti P and Lo Cascio V: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM; relation to metabolic control. Diabetologia 1995: 38;1122-1124.
13. Dechenes CJ, Verchere CB, Andrikopoulos S, Kahn SE: Human aging is associated with parallel reductions in insulin and amylin release. Am J physiol 1998: 275;E785-E791.
14. Diwadkar VA, Anderson JW, Bridges SR, Gowri MS and Oelgten PR: Postprandial low density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples, Proc Soc Exp Biol Med 1999: 222;178 -184.
15. Duprez D, De Buyzere M, Rietzschel ER and Clement DL: Aldosterone andvascular damage; Curr Hypertens Rep 2000: 2;327-334.
16. Enkins AJ, Klein RL, Chassereau CN, Hermayer KL and Lopes- Virella MF: LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. 1996: 45;762-767.
17. Farlane Mc and Sowers: Cardiovascular Endocrinology. J Clin Endocrinol Metab, February 2003: 88(2); 516-523.
18. Giugliano D: Circulating adhesion molecules in humans; role of hyperglycemia and hyperinsulinemia. Circulation 2000: 101;2247-2251.
19. Giugliano D, Ceriello A and Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996: 19; 257-267.
20. Giugliano D, Marfella R, Coppola L, Verrazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C and D'Onofrio F: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine; evidence for reduced availability of nitric oxide during hyperglycemia.1997; 95: 1783-1790.
21. Goodman and Gilman: Pharmacological basis of therapeutics; keto acid, 11thed, mcgraw-hill medical publishing division. (2006)1699.
22. Griendling KK, Sorescu D and Ushio-Fukai M: NAD(P)H oxidase; role in cardiovascular biology and disease. Circ Res 2000: 86;494 -501.
23. Hopkins PN, Hunt SC, Wu LL, Williams GH and Williams: Hypertension dyslipidemia and insulin resistance; links in a chain or spokes on a wheel? Curr Opin Lipidol. 1996: 7; 241-253.
24. Hudson Barry I, Hofmann Marion A, Bucciarelli Loredana, Wendt Thoralf, Moser Bernhard, Lu Yan, Qu Wu, Stern David M, D'Agati Vivette, Yan Shi Du, Yan Shi Fang,Grant Peter J and Ann Marie Schmidt: Glycation and diabetes; The RAGE connection. Circ. Res. 1998: 37;586-600.
25. Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA, Brown MD, Miller M, PJ Avery, Alberti KG and Walker M: Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia 1997: 40;1185- 1190.
26. Imenta W, Korytkowski M, Mitrakou A., Jenssen T, Yki- Jarvinen H, Evron W, Dailey G and Gerich G: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM; evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 1995: 273; 1855-1861.
27. Jones RL and Peterson CM: Reduced fibrinogen survival in diabetes mellitus a reversible phenomenon. J Clin Invest 1979: 63;485- 493.
28. Jones RL: Fibrinopeptide-A in diabetes mellitus, relation to levels of blood glucose, fibrinogen disappearance and hemodynamic changes. (1985) 836-843.
29. Jorgensen RG, Russo L, Mattioli L and Moore WV: Early detection of vascular dysfunction in type I diabetes. 1988: 37;292-296.
30. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H and Yasue H: Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999: 34; 146 -154.
31. Lassegue B and Clempus RE: Vascular NAD(P)H oxidases; specific features; expression; regulation. Am J Physiol Regul Integr Comp Physiol 2003: 285; R277-R297.
32. Lopes-Virella MF and Virella G: Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes 1992: 41;86-91.
33. Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A and Giugliano D: Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol 268; 1995: E 1167-E1173.
34. Muller DC, Elahi D, Tobin JD and Andres R: The effect of age on insulin: resistance ;secretion; Semin Nephrol 1996: 16; 289-298
35. Odetti P, Aragno I, Garibaldi S, Valentini S, Pronzato MA and Rolandi R: A scanning forces microscope study; Gerontology; Role of advanced glycation endproducts in aging collagen.1998: 187-191.
36. Rang HP, Dale MM, Moore JM and Ritter PK : The endocrine pancreas and the control of blood glucose, 5th ed, Livingston publication, London. 1999:380-393.
37. Rocha R, Chander PN, Zuckerman A and Stier CT: Role of aldosterone inrenal vascular injury in stroke-prone hypertensive rats. Hypertension 1999: 33;232-237.
38. Ruosladti E and Integrins J: Glucemia posprandial y riesgo cardiovascular. Clin Invest 1991: 187; 1-5.
39. Sacco RL: Reducing the risk of stroke in diabetes; what have we leant that is new? Diabetes Obes Metab 4(Suppl 1); (2002) S27-S34.
40. Sakamoto T, Ogawa H, Kawano H, Hirai N, Miyamoto S, Takazoe K, Soejima H, Kugiyama K, Yoshimura M and Yasu H: Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemos 2000: 83(3); 475-9.
41. Shige H, Ishikawa T, Suzukawa M, Ito T, Nakajima K, Higashi K, Ayaori M, Tabata S, Ohsuzu F and Nakamura H: Endotheliumdependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus. Am J Cardiol 1999: 84(10);127- 4 A9.
42. Sowers JR and Epstein M: Diabetes mellitus and associated hypertension; vascular disease and nephropathy. An update Hypertension 1995: 26;869-879.
43. Sowers JR, Epstein M and Frohlich ED: Diabetes; hypertension and cardiovascular disease. An update. Hypertension 2001: 37; 105-1059.
44. The Lancet: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus; results of the HOPE study and MICRO-HOPE substudy; Heart Outcomes Prevention Evaluation Study Investigators 2000: 355; 253-259.
45. Thornalley PJ: Cell activation by glycated proteins; AGE receptors; receptor recognition factors and functional classification of AGEs Cell Mol. Biol 1998: 44; 1013-1023.
46. Tsai EC, Hirsch IB, Brunzell JD and Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. 1994: 43;1010 -1014.
47. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B and Markowitz GS: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol 2003: 162; 1123- 1137.
48. Wolff SP, Jiang ZY and Hunt JV: Protein glycation; oxidative stress in diabetes mellitus and ageing, Free Radic. Biol. Med. 1991: 10; 339-352.
49. Yee KM and Struthers AD: Aldosterone blunts the baroreflex response in man; Clin Sci (Lond) 1998: 95; 687-692.